Decatur Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$14M |
| 2 |
Microsoft
MSFT
|
+$14M |
| 3 |
Amazon
AMZN
|
+$8.21M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$7.58M |
| 5 |
Oracle
ORCL
|
+$7.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$7.17M |
| 2 |
Intel
INTC
|
+$5.08M |
| 3 |
CSX Corp
CSX
|
+$4.77M |
| 4 |
Match Group
MTCH
|
+$4.28M |
| 5 |
Colgate-Palmolive
CL
|
+$3.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.85% |
| 2 | Consumer Discretionary | 16.84% |
| 3 | Healthcare | 16.05% |
| 4 | Communication Services | 8.06% |
| 5 | Consumer Staples | 6.03% |
Similar funds
Decatur Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, Decatur Capital Management held 58 positions worth $507M, up 34% from $378M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Decatur Capital Management deployed $86M of net new capital in Q3 2020, opening 4 new positions and adding to 44 existing holdings. Its largest new stake was Thermo Fisher Scientific: 18,355 shares worth $8.1M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $1.65M trimmed.
- Decatur Capital Management's largest Q3 2020 buy was Thermo Fisher Scientific: 18,355 shares worth $8.1M.
- Decatur Capital Management added most to Apple in Q3 2020, an estimated $14M increase.
- Decatur Capital Management's biggest Q3 2020 reduction was Texas Instruments, cutting an estimated $1.65M.
- Decatur Capital Management fully exited AbbVie in Q3 2020, selling an estimated $7.17M.
- Decatur Capital Management's ten largest holdings make up 49% of its $507M portfolio in Q3 2020.
- Decatur Capital Management opened 4 new positions and closed 6 in Q3 2020.
- Decatur Capital Management's portfolio value rose 34% quarter-over-quarter to $507M.
Based on Decatur Capital Management's 13F filing for Q3 2020, filed 3 Nov 2020.